|
[1]
|
Campbell, B.C.V. and Khatri, P. (2020) Stroke. The Lancet, 396, 129-142. [Google Scholar] [CrossRef]
|
|
[2]
|
Al-Bahrani, A., Taha, S., Shaath, H., et al. (2007) TNF-Alpha and IL-8 in Acute Stroke and the Modulation of These Cytokines by Antiplatelet Agents. Current Neuro-vascular Research, 4, 31-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Van, Scott, M.R., Justice, J.P., Bradfield, J.F., et al. (2000) IL-10 Reduces Th2 Cytokine Production and Eosinophilia but Augments Airway Reactivity in Allergic Mice. American Journal of Physiology Lung Cellular and Molecular Physiology, 278, L667-L674. [Google Scholar] [CrossRef]
|
|
[4]
|
Sabat, R., Grütz, G., Warszawska, K., et al. (2010) Biology of Interleukin-10. Cytokine & Growth Factor Reviews, 21, 331-344. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kumar, P., Yadav, A.K., Misra, S., et al. (2016) Role of Inter-leukin-10 (-1082A/G) Gene Polymorphism with the Risk of Ischemic Stroke: A Meta-Analysis. Neurological Research, 38, 823-830. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Nguyen, T.V., Frye, J.B., Zbesko, J.C., et al. (2016) Multi-plex Immunoassay Characterization and Species Comparison of Inflammation in Acute and Non-Acute Ischemic Infarcts in Human and Mouse Brain Tissue. Acta Neuropathologica Communications, 4, 100. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
De Bilbao, F., Arsenijevic, D., Moll, T., et al. (2009) In Vivo Over-Expression of Interleukin-10 Increases Resistance to Focal Brain Ischemia in Mice. Journal of Neurochemistry, 110, 12-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Nakajima, M., Nito, C., Sowa, K., et al. (2017) Mesen-chymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke. Mo-lecular Therapy Methods & Clinical Development, 6, 102-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Spera, P.A., Ellison, J.A., Feuerstein, G.Z., et al. (1998) IL-10 Reduces Rat Brain Injury Following Focal Stroke. Neuroscience Letters, 251, 189-192. [Google Scholar] [CrossRef]
|
|
[10]
|
Pérez-De Puig, I., Miró, F., Salas-Perdomo, A., et al. (2013) IL-10 Deficiency Exacerbates the Brain Inflammatory Response to Permanent Ischemia without Preventing Resolution of the Lesion. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 33, 1955-1966. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chi, C.H., Huang, Y.Y., Ye, S.Z., et al. (2021) Interleukin-10 Level Is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients. Journal of Affective Disorders, 293, 254-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Chen, Z., Zhang, R., Wu, Y., et al. (2020) Serum Interleukin-33 Is a Predictor of Depression in Patients with Acute Ischemic Stroke. Current Neurovascular Research, 17, 719-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chang, L.T., Yuen, C.M., Liou, C.W., et al. (2010) Link between Interleukin-10 Level and Outcome after Ischemic Stroke. Neuroimmunomodulation, 17, 223-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Worthmann, H., Tryc, A.B., Dirks, M., et al. (2015) Lipopolysaccharide Binding Protein, Interleukin-10, Interleukin-6 and C-Reactive Protein Blood Levels in Acute Ischemic Stroke Patients with Post-Stroke Infection. Journal of Neuroinflammation, 12, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chamorro, A., Amaro, S., Vargas, M., et al. (2006) Interleukin 10, Monocytes and Increased Risk of Early Infection in Ischaemic Stroke. Journal of Neurology, Neurosurgery, and Psychi-atry, 77, 1279-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Conway, S.E., Roy-O’Reilly, M., Friedler, B., et al. (2015) Sex Differences and the Role of IL-10 in Ischemic Stroke Recovery. Biology of Sex Differences, 6, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Lambertsen, K.L., Finsen, B. and Clausen, B.H. (2019) Post-Stroke Inflammation-Target or Tool for Therapy? Acta Neuropathologica, 137, 693-714. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Bushnell, C., McCullough, L.D., Awad, I.A., et al. (2014) Guide-lines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals from the American Heart Associ-ation/American Stroke Association. Stroke, 45, 1545-1588. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Pelidou, S.H., Kostulas, N., Matusevicius, D., et al. (1999) High Levels of IL-10 Secreting Cells Are Present in Blood in Cerebrovascular Diseases. European Journal of Neurology, 4, 437-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Liesz, A., Zhou, W., Na, S.Y., et al. (2013) Boosting Regulatory T Cells Limits Neuroinflammation in Permanent Cortical Stroke. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 33, 17350-17362. [Google Scholar] [CrossRef]
|
|
[21]
|
Bodhankar, S., Chen, Y., Vandenbark, A.A., et al. (2013) IL-10-Producing B-Cells Limit CNS Inflammation and Infarct Volume in Experimental Stroke. Metabolic Brain Disease, 28, 375-386. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Oleszycka, E., McCluskey, S., Sharp, F.A., et al. (2018) The Vaccine Adjuvant Alum Promotes IL-10 Production That Suppresses Th1 Responses. European Journal of Immunology, 48, 705-715. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Bodhankar, S., Chen, Y., Vandenbark, A.A., et al. (2014) Treatment of Experimental Stroke with IL-10-Producing B-Cells Reduces Infarct Size and Peripheral and CNS Inflam-mation in Wild-Type B-Cell-Sufficient Mice. Metabolic Brain Disease, 29, 59-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Liang, Q.J., Jiang, M., Wang, X.H., et al. (2015) Pre-Existing In-terleukin 10 in Cerebral Arteries Attenuates Subsequent Brain Injury Caused by Ischemia/Reperfusion. IUBMB Life, 67, 710-719. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Driessler, F., Venstrom, K., Sabat, R., et al. (2004) Molecular Mechanisms of Interleukin-10-Mediated Inhibition of NF-KappaB Activity: A Role for P50. Clinical and Experimental Immunology, 135, 64-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, Y., Jia, J., Ao, G., et al. (2014) Hydrogen Sulfide Protects Blood-Brain Barrier Integrity Following Cerebral Ischemia. Journal of Neurochemistry, 129, 827-838. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Hwang, C.J., Yun, H.M., Jung, Y.Y., et al. (2015) Reducing Effect of IL-32α in the Development of Stroke through Blocking of NF-κB, but Enhancement of STAT3 Pathways. Molecular Neurobiology, 51, 648-660. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Frenkel, D., Huang, Z., Maron, R., et al. (2005) Neuroprotection by IL-10-Producing MOG CD4+ T Cells Following Ischemic Stroke. Journal of the Neurological Sciences, 233, 125-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Frenkel, D., Huang, Z., Maron, R., et al. (2003) Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells. Journal of Immunology (Baltimore, Md: 1950), 171, 6549- 6555. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Na, S.Y., Mracsko, E., Liesz, A., et al. (2015) Amplification of Regulatory T Cells Using a CD28 Superagonist Reduces Brain Damage after Ischemic Stroke in Mice. Stroke, 46, 212-220. [Google Scholar] [CrossRef]
|
|
[31]
|
Wang, J., Xie, L., Yang, C., et al. (2015) Activated Regu-latory T Cell Regulates Neural Stem Cell Proliferation in the Subventricular Zone of Normal and Ischemic Mouse Brain through Interleukin 10. Frontiers in Cellular Neuroscience, 9, Article No. 361. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Kawada, H., Takizawa, S., Takanashi, T., et al. (2006) Administra-tion of Hematopoietic Cytokines in the Subacute Phase after Cerebral Infarction Is Effective for Functional Recovery Fa-cilitating Proliferation of Intrinsic Neural Stem/Progenitor Cells and Transition of Bone Marrow-Derived Neuronal Cells. Circulation, 113, 701-710. [Google Scholar] [CrossRef]
|
|
[33]
|
Morita, Y., Takizawa, S., Kamiguchi, H., et al. (2007) Administration of Hematopoietic Cytokines Increases the Expression of Anti-Inflammatory Cytokine (IL-10) MRNA in the Subacute Phase after Stroke. Neuroscience Research, 58, 356-360. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Liu, N., Chen, R., Du, H., et al. (2009) Expression of IL-10 and TNF-Alpha in Rats with Cerebral Infarction after Transplantation with Mesenchymal Stem Cells. Cellular & Molecular Immunology, 6, 207-213. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Pereira, L., Font-Nieves, M., Van Den Haute, C., et al. (2015) IL-10 Regulates Adult Neurogenesis by Modulating ERK and STAT3 Activity. Frontiers in Cellular Neuroscience, 9, Article No. 57. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Benakis, C., Brea, D., Caballero, S., et al. (2016) Commensal Mi-crobiota Affects Ischemic Stroke Outcome by Regulating Intestinal γδ T Cells. Nature Medicine, 22, 516-523. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Piepke, M., Clausen, B.H., Ludewig, P., et al. (2021) Interleukin-10 Im-proves Stroke Outcome by Controlling the Detrimental Interleukin-17A Response. Journal of Neuroinflammation, 18, Article No. 265. [Google Scholar] [CrossRef] [PubMed]
|